AJAva A. Jones

Ava A. Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ava A. Jones has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An evaluation of anxiety and depressive symptoms in terms of smoking among Black adults

    by Michael J. Zvolensky, Neha Pathak, Justin M. Shepherd, Bryce K. Clausen, Lorra Garey, Brooke Y. Redmond, Ava Jones, Linh Dinh, Angelica Duran, Andrea Rodriguez, et al.

  • The indirect effect of anxiety sensitivity on smoking motives through false safety behaviors among Black adults who smoke

    by Pamella Nizio, Ava A. Jones, Tanya Smit, Julia D. Buckner, Brooke Y. Redmond, Michael S. Businelle, Ezemenari M. Obasi, Michael J. Zvolensky, Lorra Garey

    Black persons who smoke begin smoking later in life and smoke fewer cigarettes per day compared to White persons who smoke (Caraballo et al., 1998; Schoenborn et al., 2013). Despite smoking at lowe...

  • Cluster analysis of anxiety sensitivity among adults who smoke

    by Michael J. Zvolensky, Janine V. Olthuis, Jafar Bakhshaie, Duckhyun Jo, Norman B. Schmidt, Luke F. Heggeness, Brooke Y. Redmond, Jessica M. Thai, Ava A. Jones

    Anxiety sensitivity, the fear of anxiety-related sensations due to beliefs that they will cause elicit harmful consequences, has emerged as an important factor in understanding the complex relations between cigarette smoking and the co-occurrence of mental/physical health concerns. Anxiety sensitivity research has focused on the global construct, with less attention given to individual lower-order dimensions. Yet, individuals vary in the degree to which they experience fears about physical, mental, and social concerns. This study examined whether individuals who smoke cluster into distinct groups based on their levels of anxiety sensitivity and, if so, their relations to mental health symptoms and smoking processes. Participants included 570 adults who smoked cigarettes daily. Results indicated that there were three homogeneous clusters ("Very High," "Moderate," and "Low") that were consistent across all anxiety sensitivity dimensions. There were group differences between the clusters, with the "Very High" group showing elevated negative emotional symptoms relative to the other two clusters. There were also differences for various smoking processes. The findings suggest that a more comprehensive approach to modeling anxiety sensitivity can be achieved using cluster analysis and that distinct groups evince theoretically aligned and clinically significant relations to mental health and smoking processes..


  • A proof-of-concept trial of a smoking cessation and anxiety sensitivity reduction smartphone application for Black adults

    by Lorra Garey, Jillian H. Robison, Cameron T. Matoska, Audrey Montgomery, Ava Jones, Emily T. Hébert, Anka A. Vujanovic, Krista M. Kezbers, Marshall K. Cheney, Matthew W. Gallagher, et al.

    Black persons who smoke are recognized as a smoking health disparity group and face higher rates of tobacco-related disease and morbidity. These disparities result from, in part, exposure to minority-related stress, which results in lower rates of quit success. Anxiety sensitivity (AS), which refers to the fear of stress, is associated with lower rates of cessation and impedes quit success among Black adults who smoke. The current study evaluated the feasibility, utilization, acceptability, and initial efficacy of a smoking cessation and AS reduction smartphone application for Black adults with elevated AS who smoke (The Mobile Anxiety Sensitivity Program for Smoking [MASP]). Participants (N = 24; 62.50% female; Mage = 47.83 years, SD = 9.32) participated in a 6-week trial of MASP. Retention was 83.33% at the 6-week follow-up and MASP utilization was high, with all features used by most participants. Participants reported that MASP was acceptable and 25% of participants reported 7-day point-prevalence abstinence, demonstrating strong utility and impact potential. Results also indicated a statistically significant reduction in AS from baseline to follow-up (p = .003, Cohen's d=.76). Black persons who smoke with AS may benefit from an accessible, adaptive app with culturally tailored treatment that addressed AS in the context of smoking cessation.


  • Open Access

    Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial

    by Pamella Nizio, Bryce Clausen, Michael S Businelle, Natalia Ponton, Ava A Jones, Brooke Y Redmond, Julia D Buckner, Ezemenari M Obasi, Michael J Zvolensky, Lorra Garey

    Background: African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. Objective: This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). Methods: Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. Results: The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. Conclusions: No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. Trial Registration: ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 International Registered Report Identifier (IRRID): DERR1-10.2196/52776


  • Open Access

    Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial (Preprint)

    by Pamella Nizio, Bryce Clausen, Michael S Businelle, Natalia Ponton, Ava A Jones, Brooke Y Redmond, Julia D Buckner, Ezemenari M Obasi, Michael J Zvolensky, Lorra Garey

    BACKGROUND African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. OBJECTIVE This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). METHODS Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. RESULTS The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. CONCLUSIONS No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. CLINICALTRIAL ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/52776

  • 064 Genome analysis reveals UV signature mutations in sun-exposed skin tumors in tuberous sclerosis complex

    by X. Zhang, J. Wang, J. Roy, A. Cartron, H. Wu, A. Jones, P. Julien-Williams, M. Wilkerson, C. Dalgard, J. Moss, et al.